Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 NTHI | General | $5.00 | 163.85K | $130.40M | -2.39 | ― | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| NTHI | NeOnc Technologies Holdings, Inc. | 5.00 | -4.26 | -45.99% |
| Name | Price | % Change | |
|---|---|---|---|
| NTHI | $5.00 | -45.99% |
BTIG analyst Thomas Shrader has maintained their bullish stance on NTHI stock, giving a Buy rating on November 6. Thomas Shrader’s rating is based on several factors, including NEO100’s encouraging
NeOnc Technologies (NTHI) announced that the FDA has granted the company a Type B End-of-Phase meeting to discuss a potential accelerated approval pathway for intranasal NEO100 in recurrent or progressive
Maxim Group analyst Jason McCarthy maintained a Buy rating on NeOnc Technologies Holdings, Inc. on November 5 and set a price target of $20.00. Jason McCarthy’s rating is based on
The latest update is out from NeOnc Technologies Holdings, Inc. ( ($NTHI) ). On Nov. 5, 2026, NeOnc reported third-quarter results and recent clinical progress. In August, its NEO100 Phase
NeOnc Technologies Holdings, Inc. ( ($NTHI) ) has shared an announcement. On November 2, 2026, NeOnc announced that data from its NEO100 and NEO212 programs would be presented in two
NeOnc Technologies Holdings, Inc. ( ($NTHI) ) has issued an update. In October 2026, NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy in Abu Dhabi with
An update from NeOnc Technologies Holdings, Inc. ( ($NTHI) ) is now available. On October 9, 2026, NeOnc Technologies Holdings, Inc. reported the resignation of Class I director Steven L.
NeOnc Technologies (NTHI) is heading toward another potentially important regulatory milestone, with the U.S. Food and Drug Administration scheduled to meet with the company on November 17, 2026, for an
NeOnc Technologies Holdings, Inc. ( ($NTHI) ) just unveiled an update. NeOnc Technologies announced on September 28, 2026, that it is scheduled to meet in person with the U.S. Food
Roth Capital analyst Jonathan Aschoff initiated coverage of NeOnc Technologies (NTHI) with a Buy rating and $20 price target The firm sees the company’s NEO100 and NEO212 launching in 2029
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| NTHI | Apr 7, 2027TBA | $130.40M | $-0.26 | $0.00 | 0.00 | -2.39 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
